TLR3+ Cancers

TLR3+ cancer

TLR3 agonists have a therapeutic potential in multiple TLR3+ cancer indications.

TLR3+ Cancers Tollys
Logo Tollys

Tollys

A new dimension in immuno-oncology

Office

41 quai Fulchiron
69005 Lyon, FRANCE

Contact us